Improving health equity in Alzheimer's disease prevention
Official title: Equity and Dissemination Core
Funded at Boston University Medical Campus · NIH-10934711 · Data updated 2026-11-12
This study is looking at ways to prevent Alzheimer's disease by understanding risk factors that we can change, and it's designed to help everyone, especially those from different backgrounds, by sharing useful information that can improve health for all.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University Medical Campus NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | September 15, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $392,713 |
| NIH project number | 1P01AG082653-01A1 |
| Project ID | NIH-10934711 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals at risk for Alzheimer's disease, particularly those from underrepresented communities such as African Americans.
✕Less likely to help
Patients who do not have a risk for Alzheimer's disease or related dementias may not receive benefit from this research.
What this research studies
This research focuses on enhancing health equity in Alzheimer's disease (AD) prevention by analyzing modifiable risk factors. It aims to produce unbiased and culturally relevant scientific findings through inclusive data analysis approaches. The project collaborates with various stakeholders to disseminate results effectively, ensuring that findings are accessible and actionable for diverse populations. By addressing disparities in AD and related dementias, the research seeks to improve population health outcomes.
Why it matters
Potential benefit: If successful, this research could lead to more effective prevention strategies for Alzheimer's disease that are tailored to diverse populations.
How similar studies have gone: Other research has shown success in addressing health disparities in Alzheimer's disease prevention, indicating that this approach has potential for impactful outcomes.
Where this research is happening
-
Boston University Medical Campus
Boston, United States Active
Researchers
- Principal investigator: Gilsanz, Paola — Boston University Medical Campus
- Study coordinator: Gilsanz, Paola
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.